162 related articles for article (PubMed ID: 38546414)
41. Successful treatment with benralizumab in a patient with eosinophilic granulomatosis with polyangiitis refractory to mepolizumab.
Menzella F; Galeone C; Ghidoni G; Ruggiero P; Capobelli S; Simonazzi A; Catellani C; Scelfo C; Livrieri F; Facciolongo N
Multidiscip Respir Med; 2021 Jan; 16(1):779. PubMed ID: 34221399
[TBL] [Abstract][Full Text] [Related]
42. Real-World Investigation of Eosinophilic-Associated Disease Overlap (REVEAL): Analysis of a US Claims Database.
Brailean A; Kwiatek J; Kielar D; Katial R; Wang X; Xu X; Kim YJ; Stokes M; Stirnadel-Farrant HA
Allergy Asthma Immunol Res; 2023 Sep; 15(5):580-602. PubMed ID: 37827978
[TBL] [Abstract][Full Text] [Related]
43. Eosinophilic Granulomatosis with Polyangiitis: Experiences in Korean Patients.
Choi CB; Park YB; Lee SW
Yonsei Med J; 2019 Aug; 60(8):705-712. PubMed ID: 31347324
[TBL] [Abstract][Full Text] [Related]
44. Comprehensive characterization of central BCL-2 family members in aberrant eosinophils and their impact on therapeutic strategies.
Odinius TO; Buschhorn L; Wagner C; Hauch RT; Dill V; Dechant M; Buck MC; Shoumariyeh K; Moog P; Schwaab J; Reiter A; Brockow K; Götze K; Bassermann F; Höckendorf U; Branca C; Jost PJ; Jilg S
J Cancer Res Clin Oncol; 2022 Feb; 148(2):331-340. PubMed ID: 34654952
[TBL] [Abstract][Full Text] [Related]
45. Case of hypereosinophilic syndrome with gastrointestinal involvement showing tissue eosinophil cytolysis.
Hagiwara SI; Ueki S; Watanabe K; Hizuka K; Etani Y
Asia Pac Allergy; 2022 Oct; 12(4):e37. PubMed ID: 36452011
[TBL] [Abstract][Full Text] [Related]
46. Update on eosinophilic granulomatosis with polyangiitis.
Furuta S; Iwamoto T; Nakajima H
Allergol Int; 2019 Oct; 68(4):430-436. PubMed ID: 31266709
[TBL] [Abstract][Full Text] [Related]
47. Eosinophilic granulomatosis with polyangiitis (formerly known as Churg-Strauss syndrome) as a differential diagnosis of hypereosinophilic syndromes.
Santos YA; Silva BR; Lira PN; Vaz LC; Mafort TT; Bruno LP; Lopes AJ
Respir Med Case Rep; 2017; 21():1-6. PubMed ID: 28337408
[TBL] [Abstract][Full Text] [Related]
48. A diagnostic score for eosinophilic granulomatosis with polyangiitis among eosinophilic disorders.
Takahashi H; Komai T; Setoguchi K; Shoda H; Fujio K
Allergol Int; 2023 Apr; 72(2):316-323. PubMed ID: 36184347
[TBL] [Abstract][Full Text] [Related]
49. Focus on the Involvement of the Nose and Paranasal Sinuses in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Nasal Cytology Reveals Infiltration of Eosinophils as a Very Common Feature.
Seccia V; Baldini C; Latorre M; Gelardi M; Dallan I; Cristofani-Mencacci L; Sellari-Franceschini S; Bartoli ML; Bacci E; Paggiaro P
Int Arch Allergy Immunol; 2018; 175(1-2):61-69. PubMed ID: 29393242
[TBL] [Abstract][Full Text] [Related]
50. Retropharyngeal edema: A rare manifestation of eosinophilic granulomatosis with polyangiitis.
Matsuno O; Minamoto S
Respir Med Case Rep; 2021; 34():101539. PubMed ID: 34745873
[TBL] [Abstract][Full Text] [Related]
51. A new index for distinguishing hypereosinophilic syndrome and antineutrophil cytoplasmic antibody-negative eosinophilic granulomatosis with polyangiitis.
Ahn SS; Yoo J; Park YB; Park JW; Lee JH; Lee SW
Asian Pac J Allergy Immunol; 2023 Sep; 41(3):244-252. PubMed ID: 33068368
[TBL] [Abstract][Full Text] [Related]
52. Real-life evidence of low-dose mepolizumab efficacy in EGPA: a case series.
Detoraki A; Tremante E; Poto R; Morelli E; Quaremba G; Granata F; Romano A; Mormile I; Rossi FW; de Paulis A; Spadaro G
Respir Res; 2021 Jun; 22(1):185. PubMed ID: 34162391
[TBL] [Abstract][Full Text] [Related]
53. Biologics for eosinophilic granulomatosis with polyangiitis.
Caminati M; Maule M; Bello F; Emmi G
Curr Opin Allergy Clin Immunol; 2023 Feb; 23(1):36-43. PubMed ID: 36413432
[TBL] [Abstract][Full Text] [Related]
54. Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis.
McBrien CN; Menzies-Gow A
Drugs Today (Barc); 2018 Feb; 54(2):93-101. PubMed ID: 29637936
[TBL] [Abstract][Full Text] [Related]
55. Eosinophilic granulomatosis with polyangiitis - Advances in pathogenesis, diagnosis, and treatment.
Fijolek J; Radzikowska E
Front Med (Lausanne); 2023; 10():1145257. PubMed ID: 37215720
[TBL] [Abstract][Full Text] [Related]
56. Early Ear, Nose and Throat Manifestations in Eosinophilic Granulomatosis with Poliangioitis: Results from Our Cohort Group and Literature Review.
D'Onofrio M; La Prova D; Galdiero MR; Cantone E; Tremante E; Mascolo M; Barbieri V; Di Nola C; Spadaro G; de Paulis A; Detoraki A
J Clin Med; 2023 Nov; 12(22):. PubMed ID: 38002582
[TBL] [Abstract][Full Text] [Related]
57. Severe congestive heart failure as the main symptom of eosinophilic granulomatosis and polyangiitis (Churg-Strauss syndrome).
Załęska J; Wiatr E; Zych J; Szopiński J; Oniszh K; Kober J; Piotrowska-Kownacka D; Roszkowski-Śliż K
Pneumonol Alergol Pol; 2014; 82(6):582-9. PubMed ID: 25339570
[TBL] [Abstract][Full Text] [Related]
58. Living without eosinophils: evidence from mouse and man.
Jackson DJ; Pavord ID
Eur Respir J; 2023 Jan; 61(1):. PubMed ID: 35953100
[TBL] [Abstract][Full Text] [Related]
59. Rapid effect of benralizumab in exacerbation of severe eosinophilic asthma associated with eosinophilic granulomatosis with polyangiitis.
Martínez-Rivera C; Garcia-Olivé I; Urrutia-Royo B; Basagaña-Torrento M; Rosell A; Abad J
BMC Pulm Med; 2021 Jan; 21(1):35. PubMed ID: 33478439
[TBL] [Abstract][Full Text] [Related]
60. Severe Asthma and Biologics: Managing Complex Patients.
Matucci A; Micheletto C; Vultaggio A
J Investig Allergol Clin Immunol; 2023 Jun; 33(3):168-178. PubMed ID: 36059229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
